Navigation Links
Zimmer Announces Quarterly Dividend for Second Quarter of 2013
Date:6/14/2013

WARSAW, Ind., June 14, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE:  ZMH; SIX: ZMH), a global leader in musculoskeletal care, today announced that its Board of Directors has authorized the payment of a cash dividend to stockholders for the second quarter of 2013. 

The cash dividend of $0.20 per share will be paid on or about July 26, 2013, to stockholders of record as of the close of business on June 28, 2013.  The dividend represents an annual dividend rate of 80 cents per share.  Future declarations of dividends are subject to approval of the Board of Directors and may be adjusted as business needs or market conditions change.

About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries.  Zimmer's 2012 sales were approximately $4.5 billion.  The Company is supported by the efforts of more than 8,500 employees worldwide.

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management.  Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially.  For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate.  This cautionary statement is applicable to all forward-looking statements contained in this document.

 

 


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cook Medical, Zimmer, Pro-Dex & J&J to Share Innovative Social Media Approaches to Marketing Device Products in Minneapolis
2. Zimmer Announces Quarterly Dividend for Second Quarter of 2012
3. Zimmer Introduces First Porous Metal Interbody Implant for Lumbar Spine in the United States
4. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2012 Results
5. Zimmer Holdings Names Christopher Begley to Board of Directors
6. Zimmer Holdings to Present at Morgan Stanley 2012 Global Healthcare Conference
7. Zimmer Holdings, Inc. Reports Third Quarter 2012 Financial Results
8. Zimmer Holdings to Present at Credit Suisse 2012 Healthcare Conference
9. Zimmer Launches Smartphone Comeback App Globally
10. Zimmer Holdings to Present at 24th Annual Piper Jaffray Healthcare Conference
11. Amarantus BioSciences Appoints Dr. Robert J. Zimmerman as Product Development Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)...  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today ... a Phase 3 clinical trial comparing the efficacy and ... the prevention of hepatic veno-occlusive disease (VOD) in adult ... who are at high risk or at very high ... be conducted across approximately 100 medical centers in ...
(Date:1/17/2017)... Research Future published a Half Cooked Research Report on Endoscopy Devices ... 33.6 million during the period 2016 to 2022 from USD 28.7 ... ... examined as a swiftly growing market and expected to grow at ... in various regions.  The increasing growth in endoscopy procedures is influencing ...
(Date:1/17/2017)... Jan. 17, 2017 Following an initial ... praised the Food and Drug Administration,s (FDA,s) final ... Drug Products by Pharmacies and Outsourcing Facilities." In ... limitation on pre-packaging -- which would have put ... to long term care (LTC) pharmacies.  ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... January 18, 2017 , ... Dr. Farhan Qureshi is ... and implants dentistry. His modern dental practice has two convenient office locations in Alexandria ... Top Rated Dentist for the Alexandria area. This award confirms the fact ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... revolutionary Active Brake Technology (ABT), an innovative braking system that allows skaters of ... Technology addresses one of the biggest concerns of beginner and intermediate skaters – ...
(Date:1/17/2017)... ... ... Anesthesia Progress – Everyone wants less pain during dental surgery, ... each patient. Dentists have several general anesthesia alternatives and finding the right option can ... Dental College in Tokyo, Japan wanted to find out which anesthetic was the better ...
(Date:1/17/2017)... ... January 17, 2017 , ... Today, to ... Carol Francis re-releases powerfully uplifting interview with medical expert and prolific author, Dr. ... and pass through tough times, Dr. Bernie Siegel energizes listeners to live life ...
(Date:1/17/2017)... ... January 17, 2017 , ... Etymotic Research will ... of Music Merchants (NAMM) winter trade show, Booth #2876, at the Anaheim Convention ... long been the gold standard for high-definition, in-ear earphones. This classic earphone has ...
Breaking Medicine News(10 mins):